[go: up one dir, main page]

TN2010000369A1 - Inhibitors of the chemokine receptor cxcr3 - Google Patents

Inhibitors of the chemokine receptor cxcr3

Info

Publication number
TN2010000369A1
TN2010000369A1 TNP2010000369A TN2010000369A TN2010000369A1 TN 2010000369 A1 TN2010000369 A1 TN 2010000369A1 TN P2010000369 A TNP2010000369 A TN P2010000369A TN 2010000369 A TN2010000369 A TN 2010000369A TN 2010000369 A1 TN2010000369 A1 TN 2010000369A1
Authority
TN
Tunisia
Prior art keywords
chemokine receptor
inhibitors
cxcr3
receptor cxcr3
benzsulphonamide
Prior art date
Application number
TNP2010000369A
Other languages
French (fr)
Inventor
David S Thorpe
Martin Smrcina
Dagmar D Cabel
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/034340 external-priority patent/WO2009105435A1/en
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of TN2010000369A1 publication Critical patent/TN2010000369A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This invention is directed to a 3-(amido or sulphamido )-4-( 4-substituted-azinyl)benzamide or benzsulphonamide compound as defined herein. The 3 -( amido or sulphamido )-(4-substituted-azinyl)benzamide or benzsulphonamide compound is useful as a inhibitor of the chemokine receptor CxCR3, and for preventing or treating a CxCR3 chemokine receptor mediated disease or condition related thereto in a patient in need of such.
TNP2010000369A 2009-02-18 2010-08-10 Inhibitors of the chemokine receptor cxcr3 TN2010000369A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/034340 WO2009105435A1 (en) 2008-02-19 2009-02-18 Inhibitors of the chemokine receptor cxcr3

Publications (1)

Publication Number Publication Date
TN2010000369A1 true TN2010000369A1 (en) 2011-12-29

Family

ID=55024498

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000369A TN2010000369A1 (en) 2009-02-18 2010-08-10 Inhibitors of the chemokine receptor cxcr3

Country Status (1)

Country Link
TN (1) TN2010000369A1 (en)

Similar Documents

Publication Publication Date Title
MX2010008397A (en) Inhibitors of the chemokine receptor cxcr3.
MX2010002732A (en) F1f0-atpase inhibitors and related methods.
WO2008116920A3 (en) 17beta-hydroxysteroid-dehydrogenase type 1 inhibitors for the treatment of hormone-dependent diseases
MX338489B (en) Hydantoin derivatives useful as kv3 inhibitors.
MA33803B1 (en) BENZODIAZEPINE BROMODOMAINE INHIBITOR
IN2012DN00971A (en)
TW201713640A (en) Bruton's tyrosine kinase inhibitors
JO2892B1 (en) Inhibitors of cyp 17
SG179085A1 (en) Pi3 kinase inhibitors and uses thereof
EA200900983A1 (en) COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS
ATE530540T1 (en) PYRIMIDONE COMPOUNDS AS GSK-3 INHIBITORS
MX2022009942A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same.
MX2007011023A (en) 2- (4-0x0-4h-quinaz0lin-3-yl) acetamides and their use as vasopressin v3 antagonists.
PH12013500274A1 (en) Heteroaryls and uses thereof
EA201200323A1 (en) COMPOUNDS AND COMPOSITIONS AS PROTEINKINASE INHIBITORS
MX2009013353A (en) Telomerase activating compounds and methods of use thereof.
EP2488025A4 (en) INHIBITORS OF SEPAPTERINE REDUCTASE FOR THE TREATMENT OF PAIN
WO2009027346A3 (en) 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-dependent diseases
EA200900091A1 (en) NEW INDICATIONS FOR THE USE OF DIRECT THROMBIN INHIBITORS IN THE TREATMENT OF CARDIOVASCULAR DISEASES
EA201270590A1 (en) ACTIVE INHIBITORS
NZ718373A (en) Substituted piperidyl-ethyl-pyrimidine as ghrelin o-acyl transferase inhibitor
WO2010042636A3 (en) Telomerase inhibitors and methods of use thereof
ATE551319T1 (en) SGK1 INHIBITORS FOR THE PROPHYLAXIS AND/OR THERAPY OF VIRAL DISEASES AND/OR CARCINOMA
MX2010007669A (en) Methods for inhibiting angiogenesis using egfl8 antagonists.
MA32933B1 (en) A combination of hspo90 inhibitors and herceptin